<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
<journal-title-group>
<journal-title>Scientific Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2045-2322</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32518361</article-id>
<article-id pub-id-type="pmc">7283485</article-id>
<article-id pub-id-type="publisher-id">66138</article-id>
<article-id pub-id-type="doi">10.1038/s41598-020-66138-y</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Continuous association of total bile acid levels with the risk of small for gestational age infants</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Chen</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Zhi Bing</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Xue</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Xing Xing</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Hua</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Mei</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xiao Lan</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cong</surname>
<given-names>Lin</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xu</surname>
<given-names>De Xiang</given-names>
</name>
<address>
<email>xudex@126.com</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chen</surname>
<given-names>Yuan Hua</given-names>
</name>
<address>
<email>yuanhuach@126.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9490 772X</institution-id><institution-id institution-id-type="GRID">grid.186775.a</institution-id><institution>School of Basic Medical Sciences, Anhui Medical University, </institution></institution-wrap>Hefei, 230032 China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1771 3402</institution-id><institution-id institution-id-type="GRID">grid.412679.f</institution-id><institution>Department of Obstetrics and Gynecology, First Affiliated Hospital of Anhui Medical University, </institution></institution-wrap>HeFei, 230022 China </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9490 772X</institution-id><institution-id institution-id-type="GRID">grid.186775.a</institution-id><institution>School of Public Health, Anhui Medical University, </institution></institution-wrap>Hefei, 230032 China </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9490 772X</institution-id><institution-id institution-id-type="GRID">grid.186775.a</institution-id><institution>School of Nursing, Anhui Medical University, </institution></institution-wrap>Hefei, 230032 China </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.452824.d</institution-id><institution>Implantation and Placental Development Laboratory, Centre for Reproductive Health, Hudson Institute of Medical Research, </institution></institution-wrap>Clayton, VIC Australia </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>9</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>9</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>10</volume>
<elocation-id>9257</elocation-id>
<history>
<date date-type="received">
<day>8</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>5</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">The association between maternal serum total bile acid (TBA) levels and small-for-gestational-age (SGA) infants is unclear. We investigated the association between various degrees of serum TBA levels and the risk of SGA infants in a Chinese population. The current study performed a cohort study among 11811 mothers with singleton pregnancy. Subjects were divided into seven categories according to maternal serum TBA levels. Interestingly, birth sizes were reduced, whereas the rate of SGA infants was increased across increasing categories of serum TBA. Compared to category 1, adjusted ORs (95%CI) for SGA infants were 0.99 (0.82–1.21) in category 2, 1.22 (0.97–1.53) in category 3, 1.99 (1.53–2.58) in category 4, 2.91 (2.16–3.93) in category 5, 4.29 (3.33–5.54) in category 6, and 9.01 (5.99–13.53) in category 7, respectively. Furthermore, adjusted ORs (95%CI) for SGA infants for each 1-SD increase in serum TBA levels were 1.36 (1.29–1.43) among all subjects, 2.40 (1.82–3.45) among subjects without cholestasis, and 1.13 (1.06–1.22) among subjects with cholestasis, respectively. These results suggest that gestational cholestasis increases the risk of SGA infants. Additionally, our results indicate strong, continuous associations of serum TBA levels below those diagnostic of cholestasis with a decreased birth sizes and an increased risk of SGA infants.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Signs and symptoms</kwd>
<kwd>Risk factors</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Intrahepatic cholestasis of pregnancy (ICP), also named gestational cholestasis, is defined as the presence of pruritus in combination with elevated serum total bile acid (TBA) levels (≥10 μmol/L). ICP is one of the most prevalent obstetric disease<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. ICP occurs usually in the second half of pregnancy until delivery. The incidence of ICP ranges from 0.4% to 15% in different countries, ethnic populations and climatic conditions<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. The majority of studies had demonstrated that ICP was associated with adverse maternal outcomes, including 3-fold increased risks of gestational diabetes mellitus and pre-eclampsia<sup><xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref></sup>. A large cohort study from Sweden showed that women with ICP had increased risks of later liver and biliary tree cancer, later specifically diabetes mellitus, later autoimmune-mediated and cardiovascular diseases after childbirth<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. On the other hand, several epidemiological studies reported the association between ICP and the increased risks of adverse fetal outcomes, including spontaneous and iatrogenic preterm delivery, a low (&lt;7) 5-minute Apgar score, respiratory distress syndrome, meconium-stained fluid, stillbirth and intrauterine fetal death<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref></sup>. In addition, a report on human and rodent animal demonstrated that ICP was also associated with sex-specific increased susceptibility to severe obese, diabetic phenotype with hepatosteatosis in adult offspring, indicating a programming effect of the high bile acid exposure in utero<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup><sup>.</sup></p>
<p id="Par3">Small for gestational age (SGA), defined as fetal weight less than the 10th percentile based on gender and gestational age, is one of the leading causes for stillbirth, neonatal death and perinatal morbidity<sup><xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref></sup>. Several epidemiological reports showed that the risks of autism in childhood and cardiovascular and metabolic diseases in adulthood were increased in people born with SGA<sup><xref ref-type="bibr" rid="CR17">17</xref>–<xref ref-type="bibr" rid="CR20">20</xref></sup>. Nevertheless, no report analyzed the association between ICP and an increased risk of SGA infants in a cohort study. It is more obscure whether maternal serum TBA levels less severe than that in cholestasis are associated with an increased risk of SGA infants.</p>
<p id="Par4">The present study conducted a birth cohort study to investigate the risk of SGA infants associated with various degrees of serum TBA levels. The present study found that ICP elevated the risk of SGA infants. Additionally, our results indicate strong, continuous associations of serum TBA levels below those diagnostic of cholestasis with a decreased birth sizes and an increased risk of SGA infants.</p>
</sec>
<sec id="Sec2" sec-type="results">
<title>Results</title>
<sec id="Sec3">
<title>The demographic characteristics and laboratory measurements of study participants</title>
<p id="Par5">The demographic characteristics of study participants were presented in Table <xref ref-type="table" rid="Tab1">1</xref>. There were significant differences on maternal age, education, and mode of delivery among different groups (Table <xref ref-type="table" rid="Tab1">1</xref>). No significant differences were observed on maternal pre-pregnancy BMI, parity, and gravidity among different groups (Table <xref ref-type="table" rid="Tab1">1</xref>). The incidence of preeclampsia was significantly lower in the TBA &lt;10 μmol/L group than those in the other two groups (Table <xref ref-type="table" rid="Tab1">1</xref>). No significant differences were observed on the incidence of pregnancy-induced hypertension and gestational diabetes mellitus among different groups (Table <xref ref-type="table" rid="Tab1">1</xref>). Maternal serum alanine transaminase concentrations, aspartate transaminase concentrations, serum total bilirubin concentrations, direct bilirubin concentrations, and indirect bilirubin concentrations were measured. Results showed that those were increased across the increasing serum TBA levels categories (Table <xref ref-type="table" rid="Tab2">2</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of the study participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Demographic variables</th><th align="left" colspan="3">Serum TBA levels (μmol/L)</th><th align="left" rowspan="2">P-value</th></tr><tr><th align="left">&lt;10.0 (n = 11120)</th><th align="left">10.0–39.9 (n = 563)</th><th align="left">≥40.0 (n = 128)</th></tr></thead><tbody><tr><td align="left" colspan="5">Maternal age (years)</td></tr><tr><td>    &lt;25 [n (%)]</td><td>1636 (14.71)</td><td>121 (21.49)</td><td>37 (28.91)</td><td rowspan="3">&lt;0.001</td></tr><tr><td>    25–34 [n (%)]</td><td>8227 (73.98)</td><td>371 (65.90)</td><td>71 (55.47)</td></tr><tr><td>    ≥35 [n (%)]</td><td>1257 (11.30)</td><td>71 (12.61)</td><td>20 (15.63)</td></tr><tr><td align="left" colspan="5">Pre-pregnancy BMI (kg/m<sup>2</sup>)</td></tr><tr><td>    &lt;18.5 [n (%)]</td><td>1916 (17.23)</td><td>113 (20.07)</td><td>29 (22.66)</td><td rowspan="4">0.159</td></tr><tr><td>    18.5–22.9 [n (%)]</td><td>6875 (61.83)</td><td>328 (58.26)</td><td>79 (61.72)</td></tr><tr><td>    23.0–27.4 [n (%)]</td><td>2003 (18.01)</td><td>102 (18.12)</td><td>15 (11.72)</td></tr><tr><td>    ≥27.5 [n (%)]</td><td>326 (2.93)</td><td>20 (3.55)</td><td>5 (3.90)</td></tr><tr><td align="left" colspan="5">Maternal education (years)</td></tr><tr><td>    ≤9 (Junior school)</td><td>3547 (31.72)</td><td>288 (52.93)</td><td>74 (57.81)</td><td rowspan="3">&lt;0.001</td></tr><tr><td>    10–15 (High school)</td><td>3477 (31.09)</td><td>155 (26.47)</td><td>31 (24.22)</td></tr><tr><td>    ≥16 (University)</td><td>3689 (32.99)</td><td>111 (19.00)</td><td>15 (11.72)</td></tr><tr><td>    Data missing</td><td>407 (4.20)</td><td>9 (1.60)</td><td>8 (6.25)</td><td></td></tr><tr><td align="left" colspan="5">Mode of delivery [n (%)]</td></tr><tr><td>    Vaginal delivery</td><td>6276 (56.44)</td><td>342 (60.75)</td><td>81 (63.28)</td><td rowspan="2">0.042</td></tr><tr><td>    Cesarean delivery</td><td>4844 (43.56)</td><td>221 (39.25)</td><td>47 (36.72)</td></tr><tr><td align="left" colspan="5">Parity [n(%)]</td></tr><tr><td>    1</td><td>8288 (74.53)</td><td>418 (74.25)</td><td>89 (69.53)</td><td rowspan="2">0.432</td></tr><tr><td>    ≥2</td><td>2832 (25.47)</td><td>145 (25.75)</td><td>39 (30.47)</td></tr><tr><td align="left" colspan="5">Gravidity</td></tr><tr><td>    1</td><td>5931 (53.34)</td><td>297 (52.75)</td><td>61 (47.66)</td><td rowspan="2">0.428</td></tr><tr><td>    ≥2</td><td>5189 (46.66)</td><td>266 (47.25)</td><td>67 (52.34)</td></tr><tr><td align="left" colspan="5">Gestational diabetes mellitus [n(%)]</td></tr><tr><td>    Yes</td><td>917 (8.25)</td><td>60 (10.66)</td><td>12 (9.38)</td><td rowspan="2">0.121</td></tr><tr><td>    No</td><td>10203 (91.75)</td><td>503 (89.34)</td><td>116 (90.62)</td></tr><tr><td align="left" colspan="5">Gestational hypertension [n(%)]</td></tr><tr><td>    Yes</td><td>359 (3.23)</td><td>21 (3.73)</td><td>8 (6.25)</td><td rowspan="2">0.135</td></tr><tr><td>    No</td><td>10761 (96.77)</td><td>542 (96.27)</td><td>120 (93.75)</td></tr><tr><td align="left" colspan="5">Preeclampsia [n(%)]</td></tr><tr><td>    Yes</td><td>611 (5.49)</td><td>77 (13.68)</td><td>18 (14.06)</td><td rowspan="2">&lt;0.001</td></tr><tr><td>    No</td><td>10506 (94.51)</td><td>489 (86.32)</td><td>110 (85.94)</td></tr></tbody></table><table-wrap-foot><p>Abbreviation: TBA, total bile acid.</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Laboratory measurements within the study participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Parameter</th><th align="left" colspan="7">Serum TBA levels (μmol/L)</th></tr><tr><th align="left">&lt;2.0 (n = 3196)</th><th align="left">2.0–3.9 (n = 4580)</th><th align="left">4.0–5.9 (n = 2075)</th><th align="left">6.0–7.9 (n = 835)</th><th align="left">8.0–9.9 (n = 434)</th><th align="left">10.0–39.9 (n = 563)</th><th align="left">≥40.0 (n = 128)</th></tr></thead><tbody><tr><td>Alanine transaminase (IU/L)</td><td>13.7 ± 14.7</td><td>17.0 ± 27.5**</td><td>21.1 ± 34.1**</td><td>29.4 ± 49.9**</td><td>34.4 ± 64.1**</td><td>110.2 ± 152.6**</td><td>189.3 ± 171.4**</td></tr><tr><td>Aspartate transaminase (IU/L)</td><td>20.3 ± 13.2</td><td>21.8 ± 18.4</td><td>25.0 ± 31.2**</td><td>30.1 ± 40.2**</td><td>36.2 ± 65.1**</td><td>93.2 ± 128.8**</td><td>168.7 ± 167.0**</td></tr><tr><td>Total bilirubin (μmol/L)</td><td>8.1 ± 3.4</td><td>8.1 ± 11.1</td><td>7.7 ± 3.8</td><td>8.0 ± 4.1</td><td>8.7 ± 4.7</td><td>12.6 ± 11.4**</td><td>33.9 ± 68.7**</td></tr><tr><td>    Direct bilirubin (μmol/L)</td><td>1.7 ± 0.9</td><td>1.8 ± 1.9</td><td>2.0 ± 4.2</td><td>2.1 ± 1.9</td><td>2.5 ± 4.3*</td><td>7.5 ± 5.2**</td><td>24.4 ± 33.8**</td></tr><tr><td>    Indirect bilirubin (μmol/L)</td><td>6.7 ± 2.8</td><td>6.4 ± 2.9*</td><td>6.3 ± 2.9*</td><td>6.6 ± 3.3</td><td>6.5 ± 3.6</td><td>4.1 ± 5.8**</td><td>9.5 ± 10.3**</td></tr></tbody></table><table-wrap-foot><p>Abbreviation: TBA, total bile acid.</p><p>The mean differences between two groups were analyzed using least significant difference (LSD) post hoc test.</p><p>*<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01 as compared with &lt; 2.0μmol/L group.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec4">
<title>Birth sizes among different groups</title>
<p id="Par6">Subjects were divided into seven categories according to maternal serum TBA levels. Birth weight was compared among seven categories. As shown in Table <xref ref-type="table" rid="Tab3">3</xref>, birth sizes, including birth weight, birth length, head circumference and chest circumference, were decreased across increasing categories of serum TBA levels. Gestational age was also compared among seven categories. Gestational age was reduced across increasing categories of serum TBA levels (Table <xref ref-type="table" rid="Tab3">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Birth sizes and gestational age in different categories.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Parameter</th><th align="left" colspan="7">Maternal serum TBA levels (μmol/L)</th></tr><tr><th align="left">&lt;2.0 (n = 3196)</th><th align="left">2.0–3.9 (n = 4580)</th><th align="left">4.0–5.9 (n = 2075)</th><th align="left">6.0–7.9 (n = 834)</th><th align="left">8.0–9.9 (n = 434)</th><th align="left">10.0–39.9 (n = 563)</th><th align="left">≥40.0 (n = 128)</th></tr></thead><tbody><tr><td align="left" colspan="8">Birth weight (g)</td></tr><tr><td>    Mean ± SD<sup>a</sup></td><td>3288.5 ± 652.5</td><td>3213.3 ± 563.7**</td><td>3186.7 ± 602.0**</td><td>2966.2 ± 650.7**</td><td>2776.6 ± 755.0**</td><td>2847.6 ± 704.4**</td><td>2575.1 ± 685.8**</td></tr><tr><td>    Median (25<sup>th</sup>, 75<sup>th</sup>)<sup>b</sup></td><td>3310 (3000, 3700)</td><td>3300 (3000, 3550)**</td><td>3250 (2950, 3550)**</td><td>3000 (2650, 3400)**</td><td>2900 (2280, 3350)</td><td>2900 (2450, 3350)**</td><td>2550 (2100, 3000)**</td></tr><tr><td align="left" colspan="8">Birth length (cm)</td></tr><tr><td>    Mean ± SD<sup>a</sup></td><td>50.1 ± 3.3</td><td>49.9 ± 3.1**</td><td>49.8 ± 3.1**</td><td>48.9 ± 3.5**</td><td>47.9 ± 4.5**</td><td>48.3 ± 4.0**</td><td>47.1 ± 4.0**</td></tr><tr><td>    Median (25<sup>th</sup>, 75<sup>th</sup>)<sup>b</sup></td><td>50.0 (49.0, 52.0)</td><td>50.0 (49.0, 52.0)**</td><td>50.0 (49.0, 51.0)**</td><td>50.0 (48.0, 51.0)**</td><td>49.0 (46.0, 51.0)</td><td>49.0 (47.0, 51.0)**</td><td>48.0 (45.3, 50.0)**</td></tr><tr><td align="left" colspan="8">Head circumference (cm)</td></tr><tr><td>    Mean ± SD<sup>a</sup></td><td>33.7 ± 2.3</td><td>33.4 ± 2.0**</td><td>33.5 ± 2.2**</td><td>32.9 ± 2.4**</td><td>32.5 ± 2.7**</td><td>32.3 ± 2.5**</td><td>31.5 ± 2.8**</td></tr><tr><td>    Median (25<sup>th</sup>, 75<sup>th</sup>)<sup>b</sup></td><td>34.0 (32.0, 35.0)</td><td>34.0 (32.0, 35.0)**</td><td>34.0 (32.0, 35.0)**</td><td>33.0 (32.0, 34.0)**</td><td>33.0 (31.0, 34.0)</td><td>33.0 (31.0, 34.0)**</td><td>32.0 (30.0, 33.0)**</td></tr><tr><td align="left" colspan="8">Chest circumference (cm)</td></tr><tr><td>    Mean ± SD<sup>a</sup></td><td>33.5 ± 2.6</td><td>33.1 ± 2.3**</td><td>33.1 ± 2.4**</td><td>32.3 ± 2.7**</td><td>31.8 ± 3.3**</td><td>31.8 ± 2.9**</td><td>31.0 ± 2.9**</td></tr><tr><td>    Median (25<sup>th</sup>, 75<sup>th</sup>)<sup>b</sup></td><td>34.0 (32.0, 35.0)</td><td>33.0 (32.0, 34.0)**</td><td>33.0 (32.0, 34.0)**</td><td>33.0 (31.0, 34.0)**</td><td>32.0 (30.0, 34.0)</td><td>32.0 (30.0, 34.0)**</td><td>31.0 (29.0, 33.0)**</td></tr><tr><td align="left" colspan="8">Gestational age (wks)</td></tr><tr><td>    Mean ± SD<sup>a</sup></td><td>38.9 + 2.3</td><td>39.0 + 2.4</td><td>38.8 + 2.5</td><td>38.2 + 2.6**</td><td>37.6 + 3.1**</td><td>37.8 + 2.7**</td><td>36.6 + 2.7**</td></tr><tr><td>    Median (25<sup>th</sup>, 75<sup>th</sup>)<sup>b</sup></td><td>39.4 (38.4, 40.3)</td><td>39.4 (38.4, 40.3)</td><td>39.3 (38.3, 40.3)</td><td>38.9 (37.1, 40.0)**</td><td>38.4 (35.8, 39.9)**</td><td>38.3 (36.7, 39.6)**</td><td>37.0 (35.1, 38.3)**</td></tr></tbody></table><table-wrap-foot><p>Abbreviation: TBA, total bile acid; SD, standard deviation.</p><p><sup>a</sup>The mean differences between two groups were analyzed using least significant difference (LSD) post hoc test.</p><p><sup>b</sup>The median differences were analyzed using non-parametric statistics.</p><p>**<italic>P</italic> &lt; 0.01 as compared with &lt; 2.0μmol/L group.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec5">
<title>Association between serum TBA as a categorical variable and the risk of SGA infants</title>
<p id="Par7">Participants were divided into seven categories according to maternal serum TBA levels. The rate of SGA infants across serum TBA levels categories is shown in Fig. <xref ref-type="fig" rid="Fig1">1</xref>. With increasing categories of maternal serum TBA levels, the rate of SGA infants was increased (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Table <xref ref-type="table" rid="Tab4">4</xref> shows the associations of maternal serum TBA levels as a categorical variable with each primary outcome, including odds ratios (ORs) and 95% confidence intervals (95%CIs) for each category, as compared with the lowest category. After adjustment for confounders, there were strong associations with SGA infants that increased across increasing categories of serum TBA levels. Additionally, there were no obvious thresholds at which risk increased (Table <xref ref-type="table" rid="Tab4">4</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>Rate of SGA infants. Serum TBA categories are as follows: category 1, less than 2.0 μmol/L; category 2, 2.0 to 3.9 μmol/L; category 3, 4.0 to 5.9 μmol/L; category 4, 6.0 to 7.9 μmol/L; category 5, 8.0 to 9.9 μmol/L; category 6, 10.0 to 39.9 μmol/L; category 7, 40 μmol/L or more. SGA, small for gestational age; TBA, total bile acid.</p></caption><graphic id="d30e1428" xlink:href="41598_2020_66138_Fig1_HTML"></graphic></fig><table-wrap id="Tab4"><label>Table 4</label><caption><p>Crude and adjusted ORs for the associations between serum TBA as a categorical variable and SGA infants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameter</th><th align="left">Pregnant women (n)</th><th align="left">SGA (n)</th><th align="left">Crude OR (95% CI)</th><th align="left">Adjusted OR (95% CI) <sup>a</sup></th><th align="left">Adjusted OR (95% CI) <sup>b</sup></th></tr></thead><tbody><tr><td align="left" colspan="6">Serum TBA levels (μmol/L)</td></tr><tr><td>    &lt;2.0</td><td>3196</td><td>193</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td>    2.0–3.9</td><td>4580</td><td>278</td><td>1.01 (0.83, 1.22)</td><td>1.02 (0.85, 1.24)</td><td>0.99 (0.82, 1.21)</td></tr><tr><td>    4.0–5.9</td><td>2075</td><td>160</td><td>1.30 (1.05, 1.62)*</td><td>1.31 (1.06, 1.63)*</td><td>1.22 (0.97, 1.53)</td></tr><tr><td>    6.0–7.9</td><td>835</td><td>108</td><td>2.31 (1.80, 2.97)**</td><td>2.32 (1.81, 2.97)**</td><td>1.99 (1.53, 2.58)**</td></tr><tr><td>    8.0–9.9</td><td>434</td><td>83</td><td>3.68 (2.78, 4.87)**</td><td>3.64 (2.75, 4.82)**</td><td>2.91 (2.16, 3.93)**</td></tr><tr><td>    10.0–39.9</td><td>563</td><td>138</td><td>5.05 (3.97, 6.43)**</td><td>5.10 (4.00, 6.49)**</td><td>4.29 (3.33, 5.54)**</td></tr><tr><td>    ≥40.0</td><td>128</td><td>50</td><td>9.98 (6.80, 14.64)**</td><td>9.90 (6.74, 14.55)**</td><td>9.01 (5.99, 13.53)**</td></tr></tbody></table><table-wrap-foot><p>Abbreviation: TBA, total bile acid; SGA, small for gestational age; OR, odds ratio.</p><p><sup>a</sup>Adjustment for gestational hypertension.</p><p><sup>b</sup>Adjustment for maternal age, pre-pregnancy BMI, maternal education, parity, gestational diabetes mellitus, gestational hypertension and preeclampsia.</p><p>**<italic>P</italic> &lt; 0.01 as compared with &lt; 2.0 μmol/L group.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec6">
<title>Association between serum TBA as a continuous variable and the risk of SGA infants and birth sizes</title>
<p id="Par8">Table <xref ref-type="table" rid="Tab5">5</xref> shows the association between serum TBA as a continuous variable and the risk of SGA infants. Adjusted ORs for SAG infants for each 1-SD increase in serum TBA level were 1.36 (95%CI: 1.29, 1.43) among all subjects, 2.40 (95%CI: 1.82, 3.45) among subjects without cholestasis (TBA &lt;10.0 μmol/L), and 1.13 (95%CI: 1.06, 1.22) among subjects with cholestasis (TBA ≥10.0 μmol/L), respectively (Table <xref ref-type="table" rid="Tab5">5</xref>).<table-wrap id="Tab5"><label>Table 5</label><caption><p>Association between serum TBA as a continuous variable and the risk of SGA infants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Parameter</th><th align="left" colspan="2">Crude models</th><th align="left" colspan="2">Adjusted models<sup>b</sup></th><th align="left" colspan="2">Adjusted models<sup>c</sup></th></tr><tr><th align="left">OR (95%CI)<sup>a</sup></th><th align="left"><italic>p</italic></th><th align="left">OR (95%CI)</th><th align="left"><italic>p</italic></th><th align="left">OR (95%CI)</th><th align="left"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" colspan="7">TBA category<sup>d</sup></td></tr><tr><td>    All</td><td>1.37 (1.31, 1.43)</td><td>&lt;0.001</td><td>1.37 (1.31, 1.43)</td><td>&lt;0.001</td><td>1.36 (1.29, 1.43)</td><td>&lt;0.001</td></tr><tr><td>    &lt;10.0 μmol/L</td><td>3.41 (2.68, 4.34)</td><td>&lt;0.001</td><td>3.36 (2.64, 4.28)</td><td>&lt;0.001</td><td>2.40 (1.82, 3.45)</td><td>&lt;0.001</td></tr><tr><td>    ≥10.0 μmol/L</td><td>1.10 (1.04, 1.16)</td><td>0.001</td><td>1.10 (1.04, 1.16)</td><td>0.001</td><td>1.13 (1.06, 1.22)</td><td>0.001</td></tr></tbody></table><table-wrap-foot><p>Abbreviation: TBA, total bile acid; SGA, small for gestational age; OR, odds ratio.</p><p><sup>a</sup>ORs were for an increase in serum TBA level of 1 SD</p><p><sup>b</sup>Adjustment for gestational hypertension.</p><p><sup>c</sup>Adjustment for maternal age, BMI, parity, maternal education, gestational diabetes mellitus, gestational hypertension and preeclampsia.</p></table-wrap-foot></table-wrap></p>
</sec>
</sec>
<sec id="Sec7" sec-type="discussion">
<title>Discussion</title>
<p id="Par9">The aim of the present study was to clarify the risk of SGA infants associated with various degrees of serum TBA levels, especially less severe than that in overt cholestasis in a birth cohort study. The present study found that birth sizes, including birth weight, birth length, head circumference and chest circumference, were decreased across increasing categories of serum TBA levels. The association between serum TBA and the risk of SGA infants was analyzed. After adjustment for confounders, there were strongly associations with SGA infants that increased across the increasing serum TBA levels categories.</p>
<p id="Par10">Maternal demographic characteristics, such as maternal age, pre-pregnancy BMI, parity and maternal education, were associated with birth weight and the risk of SGA infants. A number of epidemiological studies demonstrated that advanced maternal age, primiparity and low BMI before pregnancy elevated the risks of SGA and low birth weight infants<sup><xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR23">23</xref></sup>. Several reports indicated that the risk of SGA was higher in low educational subjects compared with high educational subjects<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. On the other hand, pregnancy complications, such as gestational diabetes mellitus, gestational hypertension and pre-eclampsia, were also associated with birth weight and the risk of SGA. Several reports showed that gestational hypertension and pre-eclampsia elevated the risk of SGA infants<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. In contrast, gestational diabetes mellitus was significantly associated with higher birth weight and 2-fold increased risk of large for gestational age (LGA) infants and macrosomia<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>. The present study further estimated the adjusted ORs with 95%CI with respect to the incidence of SGA infants using multiple logistic regression models. After adjustment for these confounders, our results still found that the risk of SGA infants was increased across the increasing serum TBA levels categories.</p>
<p id="Par11">The mechanism by which elevated serum TBA increases the risk of SGA remains obscure. Several case-control studies showed that the levels of proinflammatory cytokines and chemokines in placenta and maternal serum were significantly higher in the cholestasis group as compared to the control group<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. Reports <italic>in vivo</italic> and <italic>in vitro</italic> found that bile acids stimulated the expression of a series of inflammatory cytokines and reactive oxygen species via activating both signal 1 and 2 of the NLRP3 inflammasome and NF-κB pathway<sup><xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR34">34</xref></sup>. These studies indicated that cholestasis was associated with inflammation and oxidative stress. Indeed, many epidemiological studies showed that maternal serum and umbilical cord serum TNF-α, C-reactive protein and IL-8 levels were significantly higher in the SGA group than in the control group<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. According to a recent nest case-control study, strongly nuclear NF-κB p65 immunoreactivity was observed in placentas from pregnant women with SGA infants<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Animal experiments also found that maternal inflammation and oxidative stress resulted in FGR in rodents<sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>. Therefore, we guess that inflammation and oxidative stress may play a vital role in TBA-mediated SGA. On the other hand, recent evidence suggested that the deficiency or downregulation of selective miRNA may be involved in placental-induced diseases, such as pre-eclampsia and fetal growth restriction, through the epigenetic mechanism<sup><xref ref-type="bibr" rid="CR40">40</xref>–<xref ref-type="bibr" rid="CR42">42</xref></sup>. Indeed, several studies found that bile acid, such as deoxycholic acid, inhibited miRNA expression in cell lines<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. Consequently, we speculate downregulation of miRNA in placentas may be play a key role in TBA-mediated SGA. Moreover, a recent study reported that maternal serum TBA levels at diagnosis and at delivery were correlated positively with umbilical cord blood TBA levels, which provides evidence that bile acids could transport across the placenta<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Recently, numerous reports found that bile acids induced oncosis, necrotic cell death and apoptosis<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. Thus, the present study does not exclude that elevated TBA-associated SGA is due to the direct toxic effect of bile acids.</p>
<p id="Par12">The present study laid emphasis on whether serum TBA levels less severe than that in cholestasis was associated with an increased risk of SGA infants. However, the present study has three faults. Firstly, the nutritional status, drinking and smoking during pregnancy could affect fetal growth, but we did not have data on the variable. Secondly, the present cohort included only Chinese population, so our results should be treated cautiously when branched out to other ethnic populations. Another potential fault is the lack of information on treatment to pregnant women with cholestasis. Although previous reports demonstrated that treatment with ursodeoxycholic acid, a common drug for treating cholestasis during pregnancy, did not reduce adverse perinatal outcomes in pregnant women with ICP, it was associated with the reduction of serum TBA levels in ICP patients<sup><xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR49">49</xref></sup>.</p>
<p id="Par13">In summary, the present study investigated the risk of SGA infants associated with various degrees of serum TBA levels in a large birth cohort study. The present study demonstrated that birth sizes were decreased across increasing categories of serum TBA levels. Further analysis found that ICP elevated the risk of SGA infants. Additionally, our results indicate strong, continuous associations of serum TBA levels below those diagnostic of cholestasis with a decreased birth sizes and an increased risk of SGA infants. There were no obvious thresholds at which risk increased. Thus, our study suggests the need to reconsider current criteria for diagnosing and treating ICP.</p>
</sec>
<sec id="Sec8">
<title>Subjects and Methods</title>
<sec id="Sec9">
<title>Cohort study</title>
<p id="Par14">We conducted a retrospective birth cohort in Hefei, a city of central China<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Total 13801 pregnant women who delivered at First Affiliated Hospital of Anhui Medical University between January 2011 and December 2014 were recruited. Maternal demographic characteristics and obstetric records were recorded by midwives on the Birthing Outcomes System and all data included in the study was extracted from this database. Maternal nonfasting blood samples were obtained before labor. The exclusion criteria of the current study included the following: unavailable data of detailed delivery records (n = 897), fetal deaths or stillbirths (n = 270), pregnant women giving birth to multiple births (n = 294), induced-abortions (n = 147) and unavailable serum TBA data (n = 382). Finally, 11811 (85.6%) mothers with singleton pregnancy were eligible for this study. The present study obtained ethics approval from the ethics committee of Anhui Medical University (No. 20160010). All participants signed a written informed consent for this study. All methods were carried out in accordance with the approved guidelines.</p>
</sec>
<sec id="Sec10">
<title>Measurement of serum TBA</title>
<p id="Par15">Serum TBA levels were measured using enzymatic cycling method by an automatic biochemical analyzer (Dirui CS-T300, Ltd, Changchun, China) according to a previous protocol<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>.</p>
</sec>
<sec id="Sec11">
<title>Definition of small-for-gestational age</title>
<p id="Par16">The cutoff value used for defining the small-for-gestational age (SGA) is birth weight of live-born infants below the 10<sup>th</sup> percentile for gender and gestational age from a reference population for Chinese<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>.</p>
</sec>
<sec id="Sec12">
<title>Statistical analysis</title>
<p id="Par17">SPSS 17.0 was used to analysis the data. The mean differences were analyzed using one-way ANOVA and least significant difference (LSD) post hoc test. Categorical variables were analyzed using χ2 tests. The median differences were analyzed using non-parametric statistics (Mann-Whitney U test). The incidence and odds ratio (OR) of SGA infants were calculated in different groups. Multiple logistic regression models were used to estimate the risks of SGA infants in relation to lowest TBA category by crude and adjusted ORs with 95% confidence intervals (95% CI). Linear regression was used to explore the association between serum TBA levels and birth sizes. A <italic>p</italic>-value of &lt;0.05 (two-tailed) or a 95%CI not including 1 and 0 (for relative risk) was considered statistically significant.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>These authors contributed equally: Li Li and Wei Chen.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>The authors thank Prof. Guiying Nie (from Hudson Institute of Medical Research, Australia) for assistance in reviewing the data and revising the manuscript. This study was supported by National Natural Science Foundation of China (81471467, 81630084, 81671471, 81801477), National College Students’ Innovation and Entrepreneurship Training Program (201910366007), and Key projects of Anhui provincial natural science research in colleges and universities (KJ2019A0224).</p>
</ack>
<notes notes-type="author-contribution">
<title>Author contributions</title>
<p>Y.H.C. designed research; L.L., W.C., L.M., Z.B.L., X.L., X.X.G., Y.L., H.W., M.Z. and Y.H.C. conducted research. L.L., X.L.L. and L.C. provided obstetric expertise. Y.H.C., L.L. and W.C. analyzed data and performed statistical analysis; Y.H.C. wrote paper; Y.H.C. and D.X.X. had primary responsibility for final content. All authors reviewed the manuscript.</p>
</notes>
<notes id="FPar1" notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par18">The authors declare no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williamson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Geenes</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Intrahepatic cholestasis of pregnancy</article-title>
<source/>Obstet. Gynecol.
          <year>2014</year>
<volume>124</volume>
<fpage>120</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="pmid">24901263</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joshi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>James</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Quaglia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Heneghan</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Liver disease in pregnancy</article-title>
<source/>Lancet
          <year>2010</year>
<volume>375</volume>
<fpage>594</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="pmid">20159293</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lammert</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Marschall</surname>
<given-names>HU</given-names>
</name>
<name>
<surname>Glantz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matern</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management</article-title>
<source/>J. Hepatol.
          <year>2000</year>
<volume>33</volume>
<fpage>1012</fpage>
<lpage>1021</lpage>
<pub-id pub-id-type="pmid">11131439</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geenes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Intrahepatic cholestasis of pregnancy</article-title>
<source/>World. J. Gastroenterol.
          <year>2009</year>
<volume>15</volume>
<fpage>2049</fpage>
<lpage>2066</lpage>
<pub-id pub-id-type="pmid">19418576</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wikström-Shemer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Marschall</surname>
<given-names>HU</given-names>
</name>
<name>
<surname>Ludvigsson</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Stephansson</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study</article-title>
<source/>BJOG.
          <year>2013</year>
<volume>120</volume>
<fpage>717</fpage>
<lpage>723</lpage>
<pub-id pub-id-type="pmid">23418899</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McIlvride</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Bile acids and gestation</article-title>
<source/>Mol. Aspects. Med.
          <year>2017</year>
<volume>56</volume>
<fpage>90</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="pmid">28506676</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lora</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>CE</given-names>
</name>
</person-group>
<article-title>Severe intrahepatic cholestasis of pregnancy is a risk factor for preeclampsia in singleton and twin pregnancies</article-title>
<source/>Am. J. Obstet. Gynecol.
          <year>2015</year>
<volume>213</volume>
<fpage>395.e1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">25979617</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wikström Shemer</surname>
<given-names>EA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: A population-based cohort study</article-title>
<source/>J. Hepatol.
          <year>2015</year>
<volume>63</volume>
<fpage>456</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="pmid">25772037</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geenes</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study</article-title>
<source/>Hepatology
          <year>2014</year>
<volume>59</volume>
<fpage>1482</fpage>
<lpage>1491</lpage>
<pub-id pub-id-type="pmid">23857305</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrera</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Perinatal outcomes associated with intrahepatic cholestasis of pregnancy</article-title>
<source/>J. Matern. Fetal Neonatal Med.
          <year>2018</year>
<volume>31</volume>
<fpage>1913</fpage>
<lpage>1920</lpage>
<pub-id pub-id-type="pmid">28581354</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puljic</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age</article-title>
<source/>Am. J. Obstet. Gynecol.
          <year>2015</year>
<volume>212</volume>
<fpage>667.e1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">25687562</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papacleovoulou</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal cholestasis during pregnancy programs metabolic disease in offspring</article-title>
<source/>J. Clin. Invest.
          <year>2013</year>
<volume>123</volume>
<fpage>3172</fpage>
<lpage>3181</lpage>
<pub-id pub-id-type="pmid">23934127</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>Reproductive endocrinology: maternal cholestasis and offspring metabolic abnormalities</article-title>
<source/>Nat. Rev. Endocrinol.
          <year>2013</year>
<volume>9</volume>
<fpage>567</fpage>
<lpage>568</lpage>
<pub-id pub-id-type="pmid">23959368</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blue</surname>
<given-names>NR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Comparison of Methods for the Diagnosis of Fetal Growth Restriction Between the Royal College of Obstetricians and Gynaecologists and the American College of Obstetricians and Gynecologists</article-title>
<source/>Obstet. Gynecol.
          <year>2018</year>
<volume>131</volume>
<fpage>835</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="pmid">29630011</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Fell</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>Mortality in Infants Affected by Preterm Birth and Severe Small-for-Gestational Age Birth Weight</article-title>
<source/>Pediatrics.
          <year>2017</year>
<volume>140</volume>
<fpage>e20171881</fpage>
<pub-id pub-id-type="pmid">29117948</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>New birthweight percentiles by sex and gestational age in Southern China and its comparison with the INTERGROWTH-21st Standard</article-title>
<source/>Sci. Rep.
          <year>2018</year>
<volume>8</volume>
<fpage>7567</fpage>
<pub-id pub-id-type="pmid">29765081</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moore</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Kneitel</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Autism risk in small- and large-for-gestational-age infants</article-title>
<source/>Am. J. Obstet. Gynecol.
          <year>2012</year>
<volume>206</volume>
<fpage>314.e1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">22464070</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brøns</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Saltbæk</surname>
<given-names>PN</given-names>
</name>
<name>
<surname>Friedrichsen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Vaag</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Endocrine and metabolic diurnal rhythms in young adult men born small vs appropriate for gestational age</article-title>
<source/>Eur. J. Endocrinol.
          <year>2016</year>
<volume>175</volume>
<fpage>29</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">27252486</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crispi</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cardiovascular programming in children born small for gestational age and relationship with prenatal signs of severity</article-title>
<source/>Am. J. Obstet. Gynecol.
          <year>2012</year>
<volume>207</volume>
<fpage>121.e1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">22717268</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glantz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marschall</surname>
<given-names>HU</given-names>
</name>
<name>
<surname>Mattsson</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates</article-title>
<source/>Hepatology
          <year>2004</year>
<volume>40</volume>
<fpage>467</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="pmid">15368452</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>YH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pre-pregnancy underweight and obesity are positively associated with small-for-gestational-age infants in a Chinese population</article-title>
<source/>Sci. Rep.
          <year>2019</year>
<volume>9</volume>
<fpage>15544</fpage>
<pub-id pub-id-type="pmid">31664141</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dzakpasu</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Contribution of prepregnancy body mass index and gestational weight gain to adverse neonatal outcomes: population attributable fractions for Canada</article-title>
<source/>BMC. Pregnancy Childbirth
          <year>2015</year>
<volume>15</volume>
<fpage>21</fpage>
<pub-id pub-id-type="pmid">25652811</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>SS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Obstetric and Neonatal Risks Among Obese Women Without Chronic Disease</article-title>
<source/>Obstet. Gynecol.
          <year>2016</year>
<volume>128</volume>
<fpage>104</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="pmid">27275800</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujiwara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kawachi</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Income inequality, parental socioeconomic status, and birth outcomes in Japan</article-title>
<source/>Am. J. Epidemiol.
          <year>2013</year>
<volume>177</volume>
<fpage>1042</fpage>
<lpage>1052</lpage>
<pub-id pub-id-type="pmid">23576676</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamura</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Different Risk Factors for Very Low Birth Weight, Term-Small-for-Gestational-Age, or Preterm Birth in Japan</article-title>
<source/>Int. J. Environ. Res. Public Health
          <year>2018</year>
<volume>15</volume>
<fpage>369</fpage>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panaitescu</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chronic hypertension and adverse pregnancy outcome: a cohort study</article-title>
<source/>Ultrasound Obstet. Gynecol.
          <year>2017</year>
<volume>50</volume>
<fpage>228</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="pmid">28436175</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hung</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SF</given-names>
</name>
</person-group>
<article-title>Risk of abnormal fetal growth in women with early- and late-onset preeclampsia</article-title>
<source/>Pregnancy Hypertens
          <year>2018</year>
<volume>12</volume>
<fpage>201</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="pmid">29104027</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martino.</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal Body Weight and Gestational Diabetes Differentially Influence Placental and Pregnancy Outcomes</article-title>
<source/>J. Clin. Endocrinol. Metab.
          <year>2016</year>
<volume>101</volume>
<fpage>59</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">26513002</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lekva</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prediction of Gestational Diabetes Mellitus and Pre-diabetes 5 Years Postpartum using 75 g Oral Glucose Tolerance Test at 14-16 Weeks’ Gestation</article-title>
<source/>Sci. Rep.
          <year>2018</year>
<volume>8</volume>
<fpage>13392</fpage>
<pub-id pub-id-type="pmid">30190548</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CR</given-names>
</name>
</person-group>
<article-title>Effect of Histone Deacetylase HDAC3 on Cytokines IL-18, IL-12 and TNF-α in Patients with Intrahepatic Cholestasis of Pregnancy</article-title>
<source/>Cell. Physiol. Biochem.
          <year>2017</year>
<volume>42</volume>
<fpage>1294</fpage>
<lpage>1302</lpage>
<pub-id pub-id-type="pmid">28697498</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biberoglu</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of inflammation in intrahepatic cholestasis of pregnancy</article-title>
<source/>J. Obstet. Gynaecol. Res.
          <year>2016</year>
<volume>42</volume>
<fpage>252</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="pmid">26786878</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis</article-title>
<source/>Cell Metab.
          <year>2017</year>
<volume>25</volume>
<fpage>856</fpage>
<lpage>867.e5</lpage>
<pub-id pub-id-type="pmid">28380377</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Boyer</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Mechanisms of bile acid mediated inflammation in the liver</article-title>
<source/>Mol. Aspects Med.
          <year>2017</year>
<volume>56</volume>
<fpage>45</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">28606651</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Obeticholic Acid Protects against Gestational Cholestasis-Induced Fetal Intrauterine Growth Restriction in Mice</article-title>
<source/>Oxid. Med. Cell. Longev.
          <year>2019</year>
<volume>2019</volume>
<fpage>7419249</fpage>
<pub-id pub-id-type="pmid">31827696</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tosun</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia</article-title>
<source/>J. Matern. Fetal Neonatal Med.
          <year>2010</year>
<volume>23</volume>
<fpage>880</fpage>
<lpage>886</lpage>
<pub-id pub-id-type="pmid">20441409</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amarilyo</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased cord serum inflammatory markers in small-for-gestational-age neonates</article-title>
<source/>J. Perinatol.
          <year>2011</year>
<volume>31</volume>
<fpage>30</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">20410909</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal zinc deficiency during pregnancy elevates the risks of fetal growth restriction: a population-based birth cohort study</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>11262</fpage>
<pub-id pub-id-type="pmid">26053136</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>YH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Obeticholic Acid Protects against Lipopolysaccharide-Induced Fetal Death and Intrauterine Growth Restriction through Its Anti-Inflammatory Activity</article-title>
<source/>J. Immunol.
          <year>2016</year>
<volume>197</volume>
<fpage>4762</fpage>
<lpage>4770</lpage>
<pub-id pub-id-type="pmid">27821667</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>YH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vitamin D3 inhibits lipopolysaccharide-induced placental inflammation through reinforcing interaction between vitamin D receptor and nuclear factor kappa B p65 subunit</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>10871</fpage>
<pub-id pub-id-type="pmid">26065916</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiofalo</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Do miRNAs Play a Role in Fetal Growth Restriction? A Fresh Look to a Busy Corner</article-title>
<source/>Biomed. Res. Int.
          <year>2017</year>
<volume>2017</volume>
<fpage>6073167</fpage>
<pub-id pub-id-type="pmid">28466013</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laganà</surname>
<given-names>AS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>miRNA expression for early diagnosis of preeclampsia onset: hope or hype?</article-title>
<source/>J. Matern. Fetal Neonatal Med.
          <year>2018</year>
<volume>6</volume>
<fpage>817</fpage>
<lpage>821</lpage>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balaguer</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-30d deficiency during preconception affects endometrial receptivity by decreasing implantation rates and impairing fetal growth</article-title>
<source/>Am. J. Obstet. Gynecol.
          <year>2019</year>
<volume>221</volume>
<fpage>46.e1</fpage>
<lpage>46.e16</lpage>
<pub-id pub-id-type="pmid">30826341</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigues</surname>
<given-names>PM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>17528</fpage>
<pub-id pub-id-type="pmid">26621219</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krattinger</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chenodeoxycholic acid significantly impacts the expression of miRNAs and genes involved in lipid, bile acid and drug metabolism in human hepatocytes</article-title>
<source/>Life Sci.
          <year>2016</year>
<volume>156</volume>
<fpage>47</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">27174168</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brouwers</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels</article-title>
<source/>Am. J. Obstet. Gynecol.
          <year>2015</year>
<volume>212</volume>
<fpage>100.e1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">25046809</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Sanchez</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Protective role of biliverdin against bile acid-induced oxidative stress in liver cells</article-title>
<source/>Free Radic. Biol. Med.
          <year>2016</year>
<volume>97</volume>
<fpage>466</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="pmid">27387768</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hohenester</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Physiological hypoxia prevents bile salt-induced apoptosis in human and rat hepatocytes</article-title>
<source/>Liver. Int.
          <year>2014</year>
<volume>34</volume>
<fpage>1224</fpage>
<lpage>1231</lpage>
<pub-id pub-id-type="pmid">24164780</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chappell</surname>
<given-names>LC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial</article-title>
<source/>Lancet.
          <year>2019</year>
<volume>394</volume>
<fpage>849</fpage>
<lpage>860</lpage>
<pub-id pub-id-type="pmid">31378395</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grymowicz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Czajkowski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Smolarczyk</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid</article-title>
<source/>Scand. J. Gastroenterol.
          <year>2016</year>
<volume>51</volume>
<fpage>78</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">26152830</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel electrochemical biosensor for ultrasensitive detection of serum total bile acids based on enzymatic reaction combined with the double oxidation circular amplification strategy</article-title>
<source/>Biosens. Bioelectron.
          <year>2018</year>
<volume>118</volume>
<fpage>31</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">30055417</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Birth weight reference percentiles for Chinese</article-title>
<source/>PLoS. One.
          <year>2014</year>
<volume>9</volume>
<fpage>e104779</fpage>
<pub-id pub-id-type="pmid">25127131</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>